CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 97 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,893,300 | -12.8% | 666,661 | 0.0% | 0.56% | -17.4% |
| Q3 2022 | $4,467,000 | +110.2% | 666,661 | +32.1% | 0.68% | +102.7% |
| Q2 2022 | $2,125,000 | -9.2% | 504,661 | +267.8% | 0.34% | +53.0% |
| Q1 2017 | $2,340,000 | +106.7% | 137,212 | +24.7% | 0.22% | -1.4% |
| Q4 2016 | $1,132,000 | +12.0% | 110,000 | +10.0% | 0.22% | +20.0% |
| Q3 2016 | $1,011,000 | -10.0% | 100,000 | 0.0% | 0.18% | -22.9% |
| Q2 2016 | $1,123,000 | -17.8% | 100,000 | 0.0% | 0.24% | -16.4% |
| Q1 2016 | $1,366,000 | – | 100,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |